Stockreport

H.C. Wainwright Highlight Curative Potential of Legend Biotech Corporation (LEGN)'s Carvykti Despite Sales Miss [Yahoo! Finance]

Legend Biotech Corporation - American Depositary Shares  (LEGN) 
PDF TheFly reported on January 22 that H.C. Wainwright lowered LEGN's price target to $50 from $60 but kept a Buy rating, noting Q4 Carvykti sales of $555M missed the $582M [Read more]